Related Experiment Videos
Male contraception involving testosterone supplementation: possible increased risks of prostate cancer?
Lancet (London, England)
|February 21, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.
Cellular and molecular life sciences : CMLS·2004
Hypothalamic hormones and cancer.
Frontiers in neuroendocrinology·2001
Peptide analogs in the therapy of prostate cancer.
The Prostate·2000
Efficacy and safety of luteinizing hormone-releasing hormone antagonist cetrorelix in the treatment of symptomatic benign prostatic hyperplasia.
The Journal of clinical endocrinology and metabolism·1998
Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.
Human reproduction (Oxford, England)·1997
Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview.
Human reproduction (Oxford, England)·1995
Understanding peripheral arterial disease in the current era.
Lancet (London, England)·2026
Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.
Lancet (London, England)·2026
Developing roadmaps for advancing practice, research, and policy in the arts and health.
Lancet (London, England)·2026
Precision prevention and early detection: framework for a new clinical cancer control pathway.
Lancet (London, England)·2026